Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 22;10(11):3263.
doi: 10.3390/cells10113263.

Treatable Traits in Chronic Respiratory Disease: A Comprehensive Review

Affiliations

Treatable Traits in Chronic Respiratory Disease: A Comprehensive Review

Yong Qin Lee et al. Cells. .

Abstract

Chronic respiratory diseases are major contributors to the global burden of disease. While understanding of these diseases has improved, treatment guidelines have continued to rely on severity and exacerbation-based approaches. A new personalised approach, termed the "treatable traits" approach, has been suggested to address the limitations of the existing treatment strategies. We aim to systematically review the current evidence regarding treatable traits in chronic respiratory diseases and to identify gaps in the current literature. We searched the PubMed and Embase databases and included studies on treatable traits and chronic respiratory diseases. We then extracted information on prevalence, prognostic implications, treatment options and benefits from these studies. A total of 58 papers was included for review. The traits identified were grouped into five broad themes: physiological, biochemical, psychosocial, microbiological, and comorbidity traits. Studies have shown advantages of the treatable traits paradigm in the clinical setting. However, few randomised controlled trials have been conducted. Findings from our review suggest that multidisciplinary management with therapies targeted at treatable traits has the potential to be efficacious when added to the best practices currently implemented. This paradigm has the potential to improve the holistic care of chronic respiratory diseases.

Keywords: chronic respiratory disease; multidisciplinary; personalised medicine; treatable trait.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram.

References

    1. Martin M.J., Beasley R., Harrison T.W. Towards a personalised treatment approach for asthma attacks. Thorax. 2020;75:1119–1129. doi: 10.1136/thoraxjnl-2020-214692. - DOI - PubMed
    1. McDonald V.M., Clark V.L., Cordova-Rivera L., Wark P.A.B., Baines K.J., Gibson P.G. Targeting treatable traits in severe asthma: A randomised controlled trial. Eur. Respir. J. 2019;55:1901509. doi: 10.1183/13993003.01509-2019. - DOI - PubMed
    1. Cazzola M., Rogliani P., Matera M.G. The latest on the role of LAMAs in asthma. J. Allergy Clin. Immunol. 2020;146:1288–1291. doi: 10.1016/j.jaci.2020.06.014. - DOI - PubMed
    1. Chalmers J.D., Chotirmall S.H. Bronchiectasis: New therapies and new perspectives. Lancet Respir. Med. 2018;6:715–726. doi: 10.1016/S2213-2600(18)30053-5. - DOI - PubMed
    1. Connolly C., Borg C., Gittins A., Shrimanker R., Hynes G., Hinks T., Pavord I. P46 Treatable traits in a severe asthma cohort. Thorax. 2018;73:A123–A124. doi: 10.1136/thorax-2018-212555.204. - DOI

Publication types

LinkOut - more resources